CEA Grants NEB License to Patent that Covers a Process for Synthesis of Double Stranded RNA

The CEA, a French government-funded research organisation, has announced that its life science division has granted New England Biolabs Inc. a non-exclusive license under the patent family EP10618966.

This license concerns some RNAi products that NEB supplies to its customers in the research reagent field.

This patent family, owned solely by the CEA, covers a process for an enzymatic synthesis of double-stranded RNA based on the transcription of a double-stranded DNA template.